FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073620 [Registered on: 09/09/2024] Trial Registered Prospectively
Last Modified On: 07/09/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Single Arm Study 
Public Title of Study   How the Central Venous to Arterial Carbon Dioxide Gradient Affects Sepsis Outcomes 
Scientific Title of Study   Role of Central Venous to Arterial Carbon Dioxide Gradient in Outcomes of Sepsis 
Trial Acronym  SepsisCO2 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Samruddhi Chougale 
Designation  Senior Resident 
Affiliation  Pandit B.D Sharma, PGIMS, Rohtak 
Address  Department of Pulmonary and Critical Care Medicine, PGIMS, Rohtak
Santosh Niwas, Plot no. 29/30, H. No 962/10, Galli no 8, Adarshnagar, Rohtak
Rohtak
HARYANA
124001
India 
Phone  9763181707  
Fax    
Email  samru.c1990@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Dhruva Chaudhry 
Designation  Senior Professor and Head of the Department 
Affiliation  Pandit B.D Sharma, PGIMS, Rohtak 
Address  Department of Pulmonary and Critical Care Medicine, PGIMS, Rohtak
Santosh Niwas, Plot no. 29/30, H. No 962/10, Galli no 8, Adarshnagar, Rohtak
Rohtak
HARYANA
124001
India 
Phone  9763181707  
Fax    
Email  dhruvachaudhry@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Samruddhi Chougale 
Designation  Senior Resident 
Affiliation  Pandit B.D Sharma, PGIMS, Rohtak 
Address  Department of Pulmonary and Critical Care Medicine, PGIMS, Rohtak
Santosh Niwas, Plot no. 29/30, H. No 962/10, Galli no 8, Adarshnagar, Rohtak
Rohtak
HARYANA
124001
India 
Phone  9763181707  
Fax    
Email  samru.c1990@gmail.com  
 
Source of Monetary or Material Support  
Department of Pulmonary and Critical Care Medicine, PGIMS, Rohtak, Haryana, 124001 
 
Primary Sponsor  
Name  Dr Dhruva Chaudhry 
Address  Department of Pulmonary and Critical Care Medicine, PGIMS, Rohtak, Haryana, 124001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Samruddhi Chougale  PGIMS, Rohtak  Department of Pulmonary and Critical Care Medicine, PGIMS, Rohtak, Haryana, 124001
Rohtak
HARYANA 
9763181707

samru.c1990@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Biomedical Research Ethics Committee Pandit.B.D.Sharma PGIMS/UHS,Rohtak  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B95-B97||Bacterial and viral infectious agents,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Age above 18years.
2. Diagnosis of sepsis with predefined criteria.
3. Admitted in ICU/ high dependency unit (HDU). 
 
ExclusionCriteria 
Details  1. Acute Exacerbation COPD.
2. Any chronic respiratory illness with pCO 2 more than 50mm Hg.
3. Liver dysfunction defined as encephalopathy and impaired synthetic function
(international normalized ratio [INR] of ≥1.5) 22 , a patient with cirrhosis or pre-existing
liver disease.
4. Pregnant female.
5. End stage malignancy cases or cases admitted with treatment related complications.
6. Do not resuscitate orders. 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Role of Central venous to arterial carbon dioxide gradient in predicting sepsis outcomes  Time at which patient gets discharged from the ICU or died in the ICU 
 
Secondary Outcome  
Outcome  TimePoints 
Change in ΔpCO2 from 0 to 2 hours & association with sepsis outcomes.  Time at which patient gets discharged from the ICU or died in the ICU 
Change in ΔpCO 2 from 0 to 6 hours & association with sepsis outcomes.
 
Time at which patient gets discharged from the ICU or died in the ICU 
Change in ΔpCO 2 & association with lactate clearance.
 
Time at which patient gets discharged from the ICU or died in the ICU 
 
Target Sample Size   Total Sample Size="112"
Sample Size from India="112" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   18/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

 Sepsis is a heterogeneous and complex syndrome, characterized by a dysregulated host response to infection which can be life-threatening.

•       The major causes of admission to Intensive Care Units (ICUs)

•        Mortality rate ranges from 25-50%.

•       The association of lactate level with mortality in patients with suspected infection and sepsis is well established.

•       ΔpCO2 reflects the difference in partial pressure of carbon dioxide (pCO2) between central venous blood and arterial blood.

•       It has been proposed as an indicator of tissue perfusion and may offer insights into sepsis severity.

•       While it is not a direct measure of oxygen delivery, ΔpCO2 can provide valuable information about the adequacy of tissue perfusion and the presence of global tissue hypoxia.

•       This study aimed to determine the change in central venous and arterial pCO2 difference (ΔpCO2 ) at 0 and 6 hours to predict outcome in sepsis patients. This can act as an alternative marker to lactate clearance.


 
Close